Advanced Medicine

Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies

Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?

Genetic insights may offer shortcuts along the clinical development pathway, bringing new therapeutics to market faster

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?

CEO and Founder of EnteroBiotix James McIllroy shares the wonders of manipulating our microbial passengers.

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine